A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients with Huntington's Disease.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Bertram, Kelly (Chief Investigator (CI))
- Burn, Katherine (Project Manager)
Project: Research